These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
508 related articles for article (PubMed ID: 33019382)
1. Integrated analysis identifies a long non-coding RNAs-messenger RNAs signature for prediction of prognosis in hepatitis B virus-hepatocellular carcinoma patients. Bai Z; Li H; Li C; Sheng C; Zhao X Medicine (Baltimore); 2020 Oct; 99(40):e21503. PubMed ID: 33019382 [TBL] [Abstract][Full Text] [Related]
2. Identification of a Novel Eight-lncRNA Prognostic Signature for HBV-HCC and Analysis of Their Functions Based on Coexpression and ceRNA Networks. Zhao X; Bai Z; Li C; Sheng C; Li H Biomed Res Int; 2020; 2020():8765461. PubMed ID: 32382578 [TBL] [Abstract][Full Text] [Related]
3. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
4. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma. Yan J; Zhou C; Guo K; Li Q; Wang Z J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981 [TBL] [Abstract][Full Text] [Related]
5. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566 [TBL] [Abstract][Full Text] [Related]
7. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma. Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128 [TBL] [Abstract][Full Text] [Related]
8. Prognostic effect of a novel long noncoding RNA signature and comparison with clinical staging systems for patients with hepatitis B virus-related hepatocellular carcinoma after hepatectomy. Wu H; Liu TT; Feng YM; Xie XY; Su XN; Qi JN; Zhu Q; Qin CY J Dig Dis; 2020 Nov; 21(11):650-663. PubMed ID: 32959529 [TBL] [Abstract][Full Text] [Related]
9. A five lncRNA signature for prognosis prediction in hepatocellular carcinoma. Sun Y; Zhang F; Wang L; Song X; Jing J; Zhang F; Yu S; Liu H Mol Med Rep; 2019 Jun; 19(6):5237-5250. PubMed ID: 31059056 [TBL] [Abstract][Full Text] [Related]
10. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma. Wang P; Zeng Z; Shen X; Tian X; Ye Q DNA Cell Biol; 2020 Apr; 39(4):615-630. PubMed ID: 32105510 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Signature Constructed of Seven Ferroptosis-Related lncRNAs Predicts the Prognosis of HBV-Related HCC. Wang W; Wang L; Song C; Mu T; Hu J; Feng H J Gastrointest Cancer; 2024 Mar; 55(1):444-456. PubMed ID: 38006465 [TBL] [Abstract][Full Text] [Related]
12. Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC. Huang K; Lu Z; Li L; Peng G; Zhou W; Ye Q Hum Cell; 2021 Nov; 34(6):1830-1842. PubMed ID: 34487338 [TBL] [Abstract][Full Text] [Related]
13. Analysis of competing endogenous RNA network identifies a poorly differentiated cancer-specific RNA signature for hepatocellular carcinoma. Chen QF; Huang T; Si-Tu QJ; Wu P; Shen L; Li W; Huang Z J Cell Biochem; 2020 Mar; 121(3):2303-2317. PubMed ID: 31642123 [TBL] [Abstract][Full Text] [Related]
14. Potentials as biomarker and therapeutic target of upregulated long non-coding RNA HLA-F antisense RNA 1 in hepatitis B virus-associated hepatocellular carcinoma. Zhang X; Li W; Li S; Zhang Z; Song W Virus Genes; 2024 Jun; 60(3):243-250. PubMed ID: 38568442 [TBL] [Abstract][Full Text] [Related]
15. Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma. Liao X; Yang C; Huang R; Han C; Yu T; Huang K; Liu X; Yu L; Zhu G; Su H; Wang X; Qin W; Deng J; Zeng X; Ye X; Peng T Cell Physiol Biochem; 2018; 48(5):1854-1869. PubMed ID: 30092592 [TBL] [Abstract][Full Text] [Related]
16. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma. Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618 [TBL] [Abstract][Full Text] [Related]
17. A novel lncRNA, TCONS_00006195, represses hepatocellular carcinoma progression by inhibiting enzymatic activity of ENO1. Yu S; Li N; Huang Z; Chen R; Yi P; Kang R; Tang D; Hu X; Fan X Cell Death Dis; 2018 Dec; 9(12):1184. PubMed ID: 30518748 [TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma. Ye J; Zhang J; Lv Y; Wei J; Shen X; Huang J; Wu S; Luo X J Cell Biochem; 2019 Aug; 120(8):13810-13825. PubMed ID: 30989713 [TBL] [Abstract][Full Text] [Related]
19. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients. Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106 [TBL] [Abstract][Full Text] [Related]
20. Identification of Long Noncoding RNA Biomarkers for Hepatocellular Carcinoma Using Single-Sample Networks. Yu X; Zhang J; Yang R; Li C Biomed Res Int; 2020; 2020():8579651. PubMed ID: 33299877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]